---
figid: PMC9250433__DM2022-5614939.004
pmcid: PMC9250433
image_filename: DM2022-5614939.004.jpg
figure_link: /pmc/articles/PMC9250433/figure/fig4/
number: Figure 4
figure_title: ''
caption: 'Pathway analysis based on different types of treatments and no treatment
  using A549 (a, b) and PC-9 (c, d) cells. (a, c) Represent the results on the Western
  blots, while (b, d) illustrate the relative protein expressions via histogram. ∗P
  < 0.05 for comparison between the treatment groups and the sham group; #P < 0.05
  for comparison between the 1 mg/ml UBE group and the UBE + PEM group.'
article_title: Ubenimex Combined with Pemetrexed Upregulates SOCS1 to Inhibit Lung
  Adenocarcinoma Progression via the JAK2-STAT3 Signaling Pathway.
citation: Quan Chen, et al. Dis Markers. 2022;2022:5614939.
year: '2022'

doi: 10.1155/2022/5614939
journal_title: Disease Markers
journal_nlm_ta: Dis Markers
publisher_name: Hindawi

keywords:
---
